首页> 美国卫生研究院文献>Clinical Pediatric Endocrinology >A Case Report of Turner Syndrome with Graves’ Disease during RecombinantHuman GH Therapy and Review of Literature
【2h】

A Case Report of Turner Syndrome with Graves’ Disease during RecombinantHuman GH Therapy and Review of Literature

机译:重组期间患有格雷夫斯病的特纳综合征病例报告人体GH疗法与文献综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

An increased incidence of Hashimoto thyroiditis has been reported in patients with Turner syndrome, but several cases of Graves’ disease were also described ten to 20 years ago. We report the case of a patient with Turner syndrome who developed Graves’ disease, 3 years after successful treatment with recombinant human growth hormone (GH). A diagnosis of Graves’ disease was made and treatment with thiamazole was started, which resulted in normalization of the thyroid function. It is important to monitor thyroid function as well as growth parameters in patients with Turner syndrome.
机译:据报道,Turner综合征患者桥本甲状腺炎的发病率增加,但在10至20年前还描述了几例Graves病病例。我们报道了在成功使用重组人类生长激素(GH)治疗3年后,发展为Graves病的Turner综合征患者的病例。诊断为格雷夫斯病并开始用噻唑治疗,从而使甲状腺功能正常化。监测特纳综合征患者的甲状腺功能以及生长参数很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号